What is it about?
We investigated how functional beta-cell mass relates to metabolic control long-term following human islet transplantation and found a functional β-cell mass of >40% provides sufficient islet reserve for sustained insulin-independence but that marked glycemic control benefits are already attained by >20% normal.
Featured Image
Read the Original
This page is a summary of: β-Cell Secretory Capacity Predicts Metabolic Outcomes over 6 Years following Human Islet Transplantation, Diabetes, December 2024, American Diabetes Association,
DOI: 10.2337/db24-0729.
You can read the full text:
Contributors
The following have contributed to this page